Cas:61-51-8 N,N-Diethyltryptamine manufacturer & supplier

Chemical Name:N,N-Diethyltryptamine

CAS.NO:61-51-8

Synonyms:diethyl-(2-indol-3-yl-ethyl)-amine;DIETHYLTRYPTAMINE;Dea no. 7434;Indole,3-(2-(diethylamino)ethyl);N,N-diethyl-N-[2-(1H-indol-3-yl)ethyl]amine;Diaethyl-(2-indol-3-yl-aethyl)-amin;3-(2-diethylaminoethyl)indole;n,n-diethyl-1h-indole-3-ethanamin;N,N-diethyltryptamine;3-(2-Diethylamino-ethyl)-indol

Molecular Formula:C₁₄H₂₀N₂

Molecular Weight:216.32200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:359.8ºC at 760 mmHg

Density:1.04g/cm3

Index of Refraction:1.591

PSA:19.03000

Exact Mass:216.16300

LogP:3.05220

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like diethyl-(2-indol-3-yl-ethyl)-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(2-Diethylamino-ethyl)-indol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,diethyl-(2-indol-3-yl-ethyl)-amine Use and application,n,n-diethyl-1h-indole-3-ethanamin technical grade,usp/ep/jp grade.

Related News: Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. N,N-Diethyltryptamine manufacturer The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15. N,N-Diethyltryptamine supplier Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. N,N-Diethyltryptamine vendor The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15. N,N-Diethyltryptamine factory Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).